:::

詳目顯示

回上一頁
題名:國際藥品試驗資料專屬權之是與非--以美國為主體之自由貿易協定為例
書刊名:法令月刊
作者:葉雲卿 引用關係
作者(外文):Yeh, Yun-ching
出版日期:2011
卷期:62:3
頁次:頁97-126
主題關鍵詞:藥品試驗資料保護智慧財產權協定北美自由貿易協定中美自由貿易協定公共衛生豁免資料專屬權Pharmaceutical data protectionData exclusivityTRIPNAFTACAFTAPublic health waiver
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(2) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:1
  • 共同引用共同引用:0
  • 點閱點閱:5
期刊論文
1.Skillington, G. Lee、Solovy, Eric M.(2003)。The Protection of Test and Other Data Required by Article 39.3 of the TRIPs Agreement。Nw. J. Int'l L. & Bus.,24,51。  new window
2.Junod, Valerie(2004)。Drug Marketing Exclusivity under United States and European Union Law。Food and Drug Law Journal,59,479。  new window
3.Halperin, Robert M.(1979)。FDA Disclosure of Safety and Effectiveness Data: A Legal and Policy Analysis。DUKE L.J,11,302-310。  new window
4.Pirt, Nancy E.(1987)。Regulation of the Export of Pharmaceuticals to Developing Countries。DUQ. L. REV.,25,255。  new window
5.Wax, Paul M.(1995)。Elixirs, diluents, and the Passage of the 1938 Federal Food,Drug and Cosmetic Act。J ANN INTERN,122(6),456-461。  new window
6.Shuren, Jeffrey E.(2001)。Essay: The Modem Regulatory Administrative State: A Response to Changing Circumstances。Harv. J. on Legis,38,291+299-301。  new window
7.Merrill, Richard A.(1996)。The Architecture of Government Regulation of Medical Products。Va. L. Rev.,82,1753+1761-1766。  new window
8.Weiswasser, Elizabeth Stotland、Danzis, Scott D.(2003)。The Hatch-Waxman Act: History, Structure, and Legacy。Antitrust Law Journal,71(2),585-608。  new window
9.Correa, Carlos Maria(2002)。Unfair Competition under the TRIPS Agreement: Protection of Data Submitted for or the Registration of Pharmaceuticals。Chi. J. Int'l L.,3,69+73。  new window
10.Fellmeth, Aaron Xavier(2004)。Secrecy, Monopoly, and Access to Pharmaceuticals in International Trade Law: Protection of Marketing Approval Data under TRIPS Agreement。Harv. Int'l LJ.,45,453-454。  new window
11.Proffe, Pedro、Spennemann, Christoph(2006)。The Impact of FTAs on Public Health Policies and TRIPS Flexibilities。Int. J. Intellectual Property Management,1,75+84。  new window
12.Stout, Maria Victira(2008)。Crossing the TRIPs Nondiscrimination Line: How CAFTA Pharmaceutical Patent Pm vision Violate TRIPS Article 27.1。B.U.J. Sci. & Tech, L.,14,177+195-196。  new window
13.Rossi, F.。Free trade agreements and TRIPS-plus measures。lint. J. Intellectual Property Management,1(1/2)。  new window
14.Cimboli, Brian(2007)。The Impact of Regional Trade Areas on International Intellectual Property Rights。IDEA,48,53+56。  new window
圖書
1.Watal, Jayashree(2001)。Intellectual Property Rights in the WTO and Developing Countries。Kluwer。  new window
2.Nair, Manish Singh(20070915)。India: Ministries Say Yes To Data Protection。Lex Orbis。  new window
3.Abbott, Frederick M.(2006)。Intellectual Property Provisions of Bilateral and Regional Trade Agreements in Light of U.S. Federal Law。International Center for Trade and Sustainable Development。  new window
其他
1.WIPO。Intellectual Property and Genetic Resources, Traditional Knowledge, and Folklore,http://www.wipo.int/about-ip/en/studies/publications/genetic_resources.htm。  new window
圖書論文
1.Reichman, Jerome H.(2006)。The International Legal Status of Undisclosed Clinical Trial Data: From Private to Public Goods?。Negotiating Health: Intellectual Property and Access to Medicines。UK:Earthscan。  new window
2.Pugatch, Meir Perez(2006)。Intellectual Property, Data Exclusivity, Innovation and Market Access。Negotiating Health: Intellectual Property and Access to Medicines。UK:Earthscan。  new window
3.Praga, Cesar(2001)。Intellectual Property。Toward Free Trade in the America: Free Trade Agreement。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
:::
無相關博士論文
 
無相關書籍
 
無相關著作
 
QR Code
QRCODE